FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease

Submitted by admin on August 28, 2019 - 10:46am
Source: 
Pharmaceutical Business Review
News Tags: 
Nourianz
Parkinson's Disease
FDA
Kyowa Hakko Kirin
Headline: 
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
snippet: 


The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing "off" episodes.

Do Not Allow Advertisers to Use My Personal information